Qureshi Mohammed Azfar, Hamidi Shabnam, Auguste Bourne L
Department of Medicine, University of Toronto, ON, Canada.
Division of Nephrology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Can J Kidney Health Dis. 2023 Aug 11;10:20543581231192748. doi: 10.1177/20543581231192748. eCollection 2023.
Incremental peritoneal dialysis (PD) offers patients newly starting dialysis less than the standard "full dose" of PD, reducing treatment burden and intrusiveness while minimizing symptoms of renal failure. Incremental PD is a cost-effective approach that has been associated with slower rates of decline in residual kidney function. This approach also produces less waste and in turn reduces environmental footprint compared to standard PD prescriptions. It also aligns with the International Society of Peritoneal Dialysis (ISPD) Practice Recommendations for high-quality, goal-oriented therapy. Awareness of incremental PD along with its advantages and limitations provides practitioners with the tools to provide more patient-centered dialysis prescriptions in appropriate populations.
增量腹膜透析（PD）为新开始透析的患者提供低于标准“全剂量”的PD治疗，减轻治疗负担和侵入性，同时将肾衰竭症状降至最低。增量腹膜透析是一种具有成本效益的方法，与残余肾功能下降速度较慢有关。与标准PD处方相比，这种方法产生的废物也更少，进而减少了对环境的影响。它还符合国际腹膜透析学会（ISPD）关于高质量、目标导向治疗的实践建议。了解增量腹膜透析及其优缺点，可为从业者提供工具，以便在合适的人群中提供更以患者为中心的透析处方。
